Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

Steven A. Narod(University of Toronto), Jean-Sébastien Brunet, Parviz Ghadirian(Université de Montréal), Mark E. Robson(Memorial Sloan Kettering Cancer Center), Ketil Heimdal(Norwegian Cancer Society), Susan L. Neuhausen(University of Utah), Dominique Stoppa-Lyonnet(Institut Curie), Caryn Lerman(Georgetown University Medical Center), Barbara Pasini(Fondazione IRCCS Istituto Nazionale dei Tumori), Patricia de los Rios(University of Toronto), Barbara Weber(University of Pennsylvania), Henry T. Lynch(Creighton University)
The Lancet
December 1, 2000
Cited by 543

Abstract


Related Papers

No related papers found

Powered by citation graph analysis